Sema4 Holdings Corp. - Class A Common Stock (NQ:SMFR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 9, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	0.3150 (250)
Ask (Size)	0.3200 (78)
Prev. Close	0.3106
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sema4 Holdings Corp. (NASDAQ: SMFR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing ↗

February 08, 2023

San Diego, CA -- (SBWIRE) -- 02/08/2023 -- An investigation was announced for current long-term investors in shares of Sema4 Holdings Corp. (NASDAQ: SMFR) concerning potential breaches of fiduciary...

Via SBWire

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

Performance

More News

Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance

January 09, 2023

From GeneDx Holdings Corp.

Via GlobeNewswire

Sema4 Holdings's Return on Invested Capital Overview ↗

December 26, 2022

Via Benzinga

What To Know About Goldman Sachs's Downgrade of Sema4 Holdings ↗

December 07, 2022

Via Benzinga

Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 30, 2022

From Sema4

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

December 29, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 12, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 09, 2022

Via Benzinga

ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday ↗

December 07, 2022

Via Benzinga

New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU

December 05, 2022

From Sema4

Via GlobeNewswire

Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction

November 14, 2022

From Sema4

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Friday ↗

December 02, 2022

Via Benzinga

NASDAQ:SMFR Investor Alert: Deadline on November 7, 2022 in Lawsuit Against Sema4 Holdings Corp. ↗

November 09, 2022

Via SBWire

Deadline Alert: Sema4 Holdings Corp. (SMFR, SMFRW) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Encourages Shareholders of Last Few Hours to Actively Participate

November 07, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

Via Benzinga

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 16, 2022

Via Benzinga

SMFR FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW

November 07, 2022

Via NewMediaWire

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bed Bath & Beyond, Sema4, Medtronic, and Palantir and Encourages Investors to Contact the Firm

November 06, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

SMFR FINAL DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW

November 06, 2022

Via NewMediaWire

SEMA4 HOLDINGS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. - SMFR

November 04, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022

November 04, 2022

From Sema4

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm

October 31, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Frequently Asked Questions

Is Sema4 Holdings Corp. - Class A Common Stock publicly traded?

Yes, Sema4 Holdings Corp. - Class A Common Stock is publicly traded.

What exchange does Sema4 Holdings Corp. - Class A Common Stock trade on?

Sema4 Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sema4 Holdings Corp. - Class A Common Stock?

The ticker symbol for Sema4 Holdings Corp. - Class A Common Stock is SMFR on the Nasdaq Stock Market